These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1080556)
1. The use of transfer factor in a patient with agammaglobulinemia. Zaldivar NM; Papageorgiou PS; Kafee S; Glade PR Pediatr Res; 1975 Jun; 9(6):541-7. PubMed ID: 1080556 [TBL] [Abstract][Full Text] [Related]
2. B lymphocytes lacking surface IG in patients with immune deficiency: initiation of IG synthesis in culture in cells of a patient with thymoma. Siegal FP; Wernet P; Dickler HB; Fu SM; Kunkel HG Birth Defects Orig Artic Ser; 1975; 11(1):40-4. PubMed ID: 50098 [TBL] [Abstract][Full Text] [Related]
3. Lymphoid cell lines from patients with "non-secretory" agammaglobulinemia produce glycosylated heavy chains which are reduced in molecular weight. Schwaber J; Rosen FS J Mol Cell Immunol; 1984; 1(5):279-91. PubMed ID: 6443854 [TBL] [Abstract][Full Text] [Related]
4. Somatic cell hybrids of mouse myeloma cells and B lymphocytes from a patient with agammaglobulinemia: failure to secrete human immunoglobulin. Schwaber JF; Rosen FS J Immunol; 1979 May; 122(5):1849-54. PubMed ID: 109516 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones. Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis. Abdou NI; Casella SR; Abdou NL; Abrahamsohn IA J Clin Invest; 1973 Sep; 52(9):2218-24. PubMed ID: 4580388 [TBL] [Abstract][Full Text] [Related]
7. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody. HayGlass KT; Naides SJ; Benacerraf B; Sy MS J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459 [TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports]. Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207 [TBL] [Abstract][Full Text] [Related]
9. Use of transfer factor in patients with depressed cellular immunity and chronic infection. Rocklin RE Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987 [TBL] [Abstract][Full Text] [Related]
10. Differentiation capacity of cultured B lymphocytes from immunodeficient patients. Wu LY; Lawton AR; Cooper MD J Clin Invest; 1973 Dec; 52(12):3180-9. PubMed ID: 4543023 [TBL] [Abstract][Full Text] [Related]
11. Suppression of immunoglobulin synthesis by transplantation of T cells from anti-mu bursectomized chickens into normal recipients. Kermani-Arab V; Leslie GA J Immunol; 1977 Aug; 119(2):530-6. PubMed ID: 18542 [No Abstract] [Full Text] [Related]
13. Deficiency of T helper cells in transient hypogammaglobulinemia of infancy. Siegel RL; Issekutz T; Schwaber J; Rosen FS; Geha RS N Engl J Med; 1981 Nov; 305(22):1307-13. PubMed ID: 6270560 [TBL] [Abstract][Full Text] [Related]
14. Imbalance in T-cell subsets of five children with congenital agammaglobulinemia and its effect on "in vitro" immunoglobulin synthesis. De Martino M; Rossi ME; Pratesi F; Vierucci A Boll Ist Sieroter Milan; 1983 Jul; 62(3):273-80. PubMed ID: 6605756 [TBL] [Abstract][Full Text] [Related]
15. [Agammaglobulinemia with the absence of circulating B-lymphocytes. 9 cases]. Bejaoui M; Barbouche MR; Mellouli F; Tirellil N; Dellagi K Presse Med; 1998 Mar; 27(12):562-6. PubMed ID: 9767948 [TBL] [Abstract][Full Text] [Related]
16. [Therapy with transfer factor in a case of recidivating herpes with polymorphous erythema]. García-Calderón PA; Alomar A; García-Calderón JV; Vich JM; De Moragas JM Med Cutan Ibero Lat Am; 1977; 5(5):361-6. PubMed ID: 368459 [TBL] [Abstract][Full Text] [Related]
17. Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes. Seeger RC; Robins RA; Stevens RH; Klein RB; Waldman DJ; Zeltzer PM; Kessler SW Clin Exp Immunol; 1976 Oct; 26(1):1-10. PubMed ID: 1087209 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks. Waldmann TA; Korsmeyer SJ; Hieter PA; Ravetch JV; Broder S; Leder P Fed Proc; 1983 May; 42(8):2498-503. PubMed ID: 6404657 [TBL] [Abstract][Full Text] [Related]
19. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955 [TBL] [Abstract][Full Text] [Related]
20. Abnormalities of immunoregulatory T cells in disorders of immune function. Reinherz EL; Rubinstein A; Geha RS; Strelkauskas AJ; Rosen FS; Schlossman SF N Engl J Med; 1979 Nov; 301(19):1018-22. PubMed ID: 158708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]